Loading
PI
Pfenex Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Schimmelpennink Evert B., was filed 13 Sept 2018.
Pfenex Inc.: what insiders have been doing
Pfenex Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). Nothing new has been filed by managers of Pfenex Inc. in twelve months, the latest record being from 5 October 2020.
Over the whole record (from 2016), the tally stands at 5 purchases and 31 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
52
Thresholds
n/a
Buy Volume
€151,999
5 ops. · all time
Sell Volume
€3M
31 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2019FY ended December 2019 · cache
Income statement
Revenue44.9M
Gross profit40.5M90% margin
Net income943.1k2.1% margin
Last declaration on 5 October 2020
Declarations52 total
5,000 sharesCommon StockSEC:0000899243-20-027421:0
10,000 sharesCommon StockSEC:0000899243-20-027414:0
90,246 sharesCommon StockSEC:0000899243-20-027428:0
16,658 sharesCommon StockSEC:0000899243-20-027411:0
10,000 sharesCommon StockSEC:0000899243-20-027411:1
11,000 sharesCommon StockSEC:0000899243-20-027436:0
801,424 shares@ US$12.0088.3% of flowCommon StockSEC:0001357550-20-000064:0
3,850,000 sharesCommon Stock, par value $0.001 per shareSEC:0000905718-20-001023:0
100,000 shares@ US$12.735811.7% of flowCommon StockSEC:0001357550-20-000062:0
770 shares@ US$3.380.9% of flowCommon StockSEC:0000899243-20-016892:0
770 shares@ US$10.232.7% of flowCommon StockSEC:0000899243-20-016892:1
17,151 shares@ US$3.3814.5% of flowCommon StockSEC:0000899243-20-006774:0
17,151 shares@ US$11.2448.3% of flowCommon StockSEC:0000899243-20-006774:1
3,000 shares@ US$10.037.6% of flowCommon StockSEC:0000899243-19-028272:0
3,950 shares@ US$10.019.9% of flowCommon StockSEC:0000899243-19-023699:0
1,800 shares@ US$10.004.5% of flowCommon StockSEC:0000899243-19-023699:1
250 shares@ US$10.010.6% of flowCommon StockSEC:0000899243-19-023699:2
6,000 shares@ US$8.0012.0% of flowCommon StockSEC:0000899243-19-023250:0
9,500 shares@ US$5.0455.8% of flowCommon StockSEC:0000899243-18-024433:0
Canonical exit: 10 Dec 2018 (T+90)
500 shares@ US$5.012.9% of flowCommon StockSEC:0000899243-18-024433:1
Canonical exit: 10 Dec 2018 (T+90)
11,000 shares@ US$4.99100.0% of flowCommon StockSEC:0000899243-18-024430:0
Canonical exit: 10 Dec 2018 (T+90)
5,000 shares@ US$4.85100.0% of flowCommon StockSEC:0000899243-18-023231:0
Canonical exit: 20 Nov 2018 (T+90)
27,894 shares0Common StockSEC:0000899243-18-002751:0
11,236 shares@ US$3.3841.3% of flowCommon StockSEC:0000899243-18-002751:1
10,000 shares@ US$4.51100.0% of flowCommon StockSEC:0000899243-17-016091:0
Canonical exit: 10 Sept 2017 (T+90)
25 of 52 declarations
About Pfenex Inc.
Pfenex Inc. is a biopharmaceutical company focused on the development of biological products and therapeutics. It leverages its technology platform to enhance the production and formulation of therapeutic proteins.
